$1.21
-0.07 (-5.47%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,534.7% upside
Low Target
$19.01
Average Target
$31.88
High Target
$45.37
Current Price
$1.21
Current
$1.21
$1.21
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Scenario Analysis
Bear Case
$19.01
1,471.1%
Low target
Base Case
$31.88
+2,534.7%
Avg target
Bull Case
$45.37
+3,649.6%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$5.07
-76.1% from high
52-Week Low
$0.96
+26.0% from low
Target vs 52W High
$31.88
+528.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.3% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.3% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -31.8% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -51.4% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -32.5% |